Avista Signs on BMS MI Unit

Avista Capital Partners, a private equity firm, has signed a definitive agreement to acquire Bristol-Myers Squibb Co.'s (NYSE: BMY) Bristol-Myers Squibb Medical Imaging unit for approximately $525 million of cash proceeds.  BMS MI is a leading supplier of medical imaging products for nuclear and ultrasound cardiovascular diagnostic imaging procedures. The transaction is expected to be completed by the end of January, subject to customary regulatory approvals. www.bms.com.